Filing Flows › Amgen (AMGN) › Q2 2026 › vs Q1 2026
Amgen (AMGN) Q2 2026 vs Q1 2026 (quarter over quarter)
Amgen's revenue rose $1.4B (+17%) from $8.6B in Q1 2026 to $10.1B in Q2 2026. Operating margin 35.0% against 30.9% (+4.0 pts).
Amgen, Q2 2026: revenue $10.1B (+10% year over year), operating margin 35.0%, net earnings $2.4B, operating cash flow $4.0B. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 35.0% | 30.9% | +4.0 pts |
| Net margin | 23.6% | 21.1% | +2.5 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $10.1B | $8.6B | $1.4B | +17% |
| Operating profit | $3.5B | $2.7B | $848M | +32% |
| Costs & expenses | $6.5B | $6.0B | $588M | +10% |
| Pre-tax earnings | $2.8B | $2.1B | $684M | +33% |
| Other expense, net | $746M | $582M | $164M | +28% |
| Net earnings | $2.4B | $1.8B | $556M | +31% |
| Income tax | $393M | $265M | $128M | +48% |
| Depreciation & amortization | $1.1B | $1.1B | −$4.0M | -0.4% |
| Share-based compensation | $165M | $75.0M | $90.0M | +120% |
| Working capital & other | $350M | −$821M | $1.2B | — |
| Operating cash flow | $4.0B | $2.2B | $1.8B | +83% |
Questions
How much did Amgen's revenue grow quarter over quarter in Q2 2026?
Amgen's revenue rose $1.4B (+17%) from $8.6B in Q1 2026 to $10.1B in Q2 2026. Operating margin 35.0% against 30.9% (+4.0 pts).